Inj., ravulizumab-cwvz 10 mg
Products billed under this code include Ultomiris.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J1303
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ultomiris | Alexion Pharmaceuticals, Inc. | 25682-0025-01 | 30 | $6,793.62 |
| Ultomiris | Alexion Pharmaceuticals, Inc. | 25682-0028-01 | 110 | $24,909.94 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $226.454 | −$0.466 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted September 17, 2026 |
| 3Q26 | $226.92 | +$4.51 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted September 15, 2026 |
| 2Q26 | $222.41 | −$1.082 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted September 15, 2026 |
| 1Q26 | $223.492 | −$0.771 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted September 15, 2026 |
| 4Q25 | $224.263 | −$0.93 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted September 8, 2026 |
| 3Q25 | $225.193 | +$4.876 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted March 10, 2026 |
| 2Q25 | $220.317 | −$0.271 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted March 10, 2026 |
| 1Q25 | $220.588 | −$0.164 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted December 19, 2025 |
| 4Q24 | $220.752 | −$0.455 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted June 11, 2025 |
| 3Q24 | $221.207 | −$0.538 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted June 11, 2025 |
| 2Q24 | $221.745 | −$0.028 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted March 11, 2025 |
| 1Q24 | $221.773 | +$0.104 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted December 19, 2024 |
| 4Q23 | $221.669 | −$0.206 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted October 10, 2024 |
| 3Q23 | $221.875 | −$0.448 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted June 5, 2024 |
| 2Q23 | $222.323 | −$0.36 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted February 23, 2024 |
| 1Q23 | $222.683 | −$0.675 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted December 6, 2023 |
| 4Q22 | $223.358 | −$0.729 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted June 22, 2023 |
| 3Q22 | $224.087 | −$0.681 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted June 9, 2023 |
| 2Q22 | $224.768 | +$0.136 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted December 14, 2022 |
| 1Q22 | $224.632 | −$0.046 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted June 8, 2022 |
| 4Q21 | $224.678 | −$0.879 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted June 2, 2022 |
| 3Q21 | $225.557 | −$0.516 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted June 2, 2022 |
| 2Q21 | $226.073 | −$0.106 | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted March 1, 2022 |
| 1Q21 | $226.179 | – | 10 MG | Inj., ravulizumab-cwvz 10 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021